U.S. Multiple Myeloma Market
U.S. Multiple Myeloma Market
RELEASE DATE
27-Mar-2007
27-Mar-2007
REGION
North America
North America
Research Code: N083-01-00-00-00
SKU: HC02000-NA-MR_07290
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02000-NA-MR_07290
Description
The U.S. Multiple Myeloma Market is a rapidly progressing field that is set to generate over $3 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of three new drugs. The dynamics of this market are changing rapidly and the forecast through 2013 highlights the major changes. This study includes patient forecasts, pipeline analysis and individual product revenue forecasts.
Table of Contents
Executive Summary
- Executive Summary
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Blood Cancer Overview
- Blood Cancer Biology
- Blood Cancer Definitions
Multiple Myeloma Overview
- Etiology
- Staging and Prognostic Factors
- Treatment Overview
Patient Forecasts
- Prevalence
- Incidence
- Mortality
- Staging
General Market Trends
- Industry Challenges and Strategies
- Market Drivers
Approved Product Analysis
Pipeline Analysis
Introduction
Market Revenue Forecasts
Product Revenue Forecasts
Decision Support Databases
Related Research
Popular Topics
The U.S. Multiple Myeloma Market is a rapidly progressing field that is set to generate over $3 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of three new drugs. The dynamics of this market are changing rapidly and the forecast through 2013 highlights the major changes. This study includes patient forecasts, pipeline analysis and individual product revenue forecasts.
No Index | No |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N083-01-00-00-00 |
Is Prebook | No |